From "The Motley Fool" July 30, 2014
"1. Biotechnology: ADMEDUS FPO (ASX: AHZ) was my top stock pick for October 2013. After rising over 100% two months later, the stock has settled back down at just $0.13 per share, or 46% higher than the price I recommended it. However, just last week I added to my holding of Admedus because I feel it is still significantly undervalued given its long-term potential. I would allocate $3,500 to this stock."
Right now its at 3c aka 34c must be really really undervalued now.
Ann: Admedus Appoints John Seaberg as Chairman, page-30
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |